Polynovo Ltd

Research Polynovo Ltd (MFJ) on Bullrun: market cap EUR 378.15M, P/E 53.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMFJ
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 378.15M
• P/E53.0
• Financial periodFY2025
• RevenueEUR 127.24M
• Revenue growth23.3%
• Net incomeEUR 13.21M
• Free cash flow-EUR 10.78M
• Gross margin95.9%

Valuation Snapshot

latest market cap is EUR 378.15M; P/E is 53.0.

About Polynovo Ltd

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction;

Frequently asked questions

What is Polynovo Ltd's market cap?

Polynovo Ltd's market capitalization is EUR 378.15M.

What is Polynovo Ltd's P/E ratio?

Polynovo Ltd's price-to-earnings (P/E) ratio is 53.0.

What does Polynovo Ltd do?

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.